On-Demand Webcast

Share

Program Content

Activities

  • Melanoma Immunotherapy
    Pathways for Optimized Adjuvant Immunotherapy Strategies in Resectable Melanoma
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 15, 2024

    Expires: February 14, 2025

Faculty

cover img faculity

Michael A. Davies, MD, PhD

Professor and Chair, Department of Melanoma Medical Oncology
Professor, Translational Molecular Pathology and Genomic Medicine
Anne and John Mendelsohn Chair in Cancer Research
University of Texas, MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Partners

AIM at Melanoma Foundation

ProCE Banner